second the fiscal our join of more for outlook and hear time performance Mike, good everyone. about the our you Thanks, us morning, to Thank quarter and rest taking year. the for to
the We performance. and Mike, for constant challenges. I the quarter. continue we my demand quarter. the in with was And planned currency review operational our a company currency commentary of segment a highlights despite our to impactful our the perspective, previously but growth quarter heard will revenue had was then From products are organic outlook. we foreign currency Healthcare as-reported services. as you've ongoing grew revenue and on in pleased see more X% shift than revenue, our strong macroeconomic Once solid organic constant quarter from to again, X% the Total
in and quarter. that supply received We in anticipated we we better to components, key up able challenges several discussed by step to would improved chain and component As last visibility quarter, we our shipments we start an September. had August, that we're the deliveries on see
in capital second we on of or Reflecting see shipments receive. We backlog, levels continue have that based to to inventory the expect scenario, components will continue the capital key constant demand basis. organic continue to of half significant service to growth see quarter solid and Consumables as currency a remained equipment our in about good the on we customers. from that were flat our
a growth consumable Our of a limited on due growth basis. is lack to procedure year-over-year
our either at believe from portfolio confidence in of operating support we delayed believe the room expect backlog, directly the million shipments sterile base the core insulation As in of shipments optimistic rising months, $XXX spending capital over for we the strengthening quarter. capital. before, XX% we and pre-pandemic at term, pickup XXX% the at million the essential were in not a procedures our Healthcare us for time. the our approximately in back large we get the our customers' equipment STERIS Hospital in coming in $XX to approximately or this revenue in cost capital second we products processing levels quarter, are to end we some were of the but to have our our significant is the second by said further quarter, do remains robust for totaled in Longer projects. over evidenced uptick surgeries, half. end provides Despite XX% Orders as quarter which department replacement will and
sequentially, revenue core currency and significantly AST second to a the on basis underlying continue our both year-over-year quarter, demand our rate grew the Moving as constant benefit teens. improved AST. in In the we to growth organic on which into second XX% high from quarter from customers. [MevX] pushed
witnessed, already they continue and winter. large profit of the From revenue at segment Sciences, for that be shipments internationally, signs have costs, can business. Similar both equipment not indicate booked are perspective, All with this installed to pieces are tested. until of the this you impacting As these lumpy fully Life as a least are through the are energy AST. U.S. and margins increased in will capital
costs basis to Sciences the compared increases. timing continue on the for of year. in with flat a was ways constant prior recoup allow the We contracts these as organic currency our look Life revenue to
revenue slipped third about timing continues by reminder, a growth Also, and in had our capital both are very the equipment We expectations. business million. $XXX shipments declines quarter service million backlog as versus our to Solid as the capital just strong in shipment around believe of a matter And was QX. $XX into hover offset consumables. a quarter
this We in are optimistic capital about the long-term demand segment. for our equipment
currency inventory management On the the not as revenue underlying the line. customers, concerned remains consumables This aseptic in our primarily barrier production by side, strong. from demand about to products perspective. due business our for trends pharma particular, a flat is in Again, long-term we're very constant about organic
declined currency segment organic constant Dental X% Our perspective. revenue a on
believe single-digit the in current some around XX% hover in for procedure to chain year-over-year is and this Dental have the XX% due on spending costs. low manage decline operating pre-COVID While relief to over We declined Despite conditions. our the experienced procedures continue were as volumes we of margins levels, supply range. revenue, macroeconomic
revenue to of XX% outlook. unchanged. organic Constant Turning currency growth expectations year full our remain
foreign currency on are we revising based as-reported revenue. challenges, However, the ongoing our
due is of foreign now reduction prior currency to As-reported revenue fluctuations. to expected X% continued a from the grow expectations X%,
outlook year, pound. continue and our currency weak $X.XX. and pricing. approximately million to to is primary this $XXX the the EPS by be improved drivers is British in revenue adjusted For of expected now by revenue as-reported The reduce euro Reflected
points for Combined, basis chain the and the inflation. contribute spending will pricing to year. margins offset and additional help year. from are will This for expecting We around now fiscal the foreign higher-than-planned currency XXX disciplined supply operating impacts
chain the our cost prior $X.XX inflation, in fiscal expect now these at year. supply of Factoring we for for $X.XX are year, earnings expectations over the incremental For labor million $XX in elements, an to and unchanged expectations. range million extraordinary increase an full our the $XX
Overall, continues an perform in high well with we additional impact business believe X% that very currency, the foreign likely. this less environment. end our range from However, is of to
come customers deliver segments trends several our continue to and our the the portfolios leveraging offering better meet allows and teams of our and advantage take customers. within together of to industry to breadth to the cross-sell value our to us by significant in of relationships needs Our business
open we facing Q&A, did challenges want for the I industry oxide. is the address Before ethylene to on
as oxide regulatory for operate. seriously our take the crucial ethylene have As the you sterile And alternative throughout oxide for world. currently, the medical the devices the U.S., always the very processing been strict of we long-term there our these demand does STERIS, responsibility an our the and and the to manage to for limited in all technology. industry EO. communities compliance of At essential capacity we quality date, standards very a people, provider safety expectations to medical ethylene facilities committed of single-use growth which is industry's and know, to not in have supply products To services is
We the of are business, is actions. by exemplified I of our long-term believe our stewards success which
have the regularly used our processes possible. deploy to the reflect facilities and adoption We of practices updated technology equipment and within our best new
our sterilization operated in years. that, to we addition, have regulatory per customers we turn these EO made the with AST for in facilities of FDA developing which to will sustainable I the improvements This cycles, Julie I adopt to to cycle. diligence for so worked have With led we contract segment. the to significantly how ease over they way continue the have used the process am within can and reduced confident have and our have And cycles. these U.S. we gas many industry more Q&A. the the begin run it is business we EO run closely with In our amount transition easily consistent the